AT378334T
Hepatitis c inhibitor compounds
Abstract
The left and right of the compound of formula wherein r3 b x for l1 l2 and rc r1 r2 are defined in the file. These compounds can be used as hcv ns3 protease inhibitors of it is used for treating hepatitis c virus infection.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
58 members in 34 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 47270903 | United States of America | P |
Members58
| Document | Office | Kind | |
|---|---|---|---|
| AU2004240704A1 | Australia | A1 | |
| CA2522577A1 | Canada | A1 | |
| WO2004103996A1 | World Intellectual Property Organization (WIPO) | A1 | |
| UY28323A1 | Uruguay | A1 | |
| US2005020503A1 | United States of America | A1 | |
| TW200508220A | Taiwan Province of China | A | |
| CL2004001161A1 | Chile | A1 | |
| PE20050204A1 | Peru | A1 | |
| NO20056047L | Norway | L | |
| MXPA05012545A | Mexico | A | |
| KR20060013671A | Republic of Korea | A | |
| ECSP056181A | Ecuador | A | |
| CO5630024A2 | Colombia | A2 | |
| EP1654261A1 | European Patent Office (EPO) | A1 | |
| BRPI0410456A | Brazil | A | |
| CN1791599A | China | A | |
| EA200501689A1 | Eurasian Patent Organization (EAPO) | A1 | |
| JP2006528937A | Japan | A | |
| ZA200508201B | South Africa | B | |
| RS20050871A | Serbia | A | |
| US2007243166A1 | United States of America | A1 | |
| EP1654261B1 | European Patent Office (EPO) | B1 | |
| AT378334TThis record | Austria | T | |
| DE602004010137D1 | Germany | D1 | |
| EA009295B1 | Eurasian Patent Organization (EAPO) | B1 | |
| DK1654261T3 | Denmark | T3 | |
| PT1654261E | Portugal | E | |
| HRP20080014T3 | Croatia | T3 | |
| PL1654261T3 | Poland | T3 | |
| SI1654261T1 | Slovenia | T1 | |
| ES2297424T3 | Spain | T3 | |
| UA83046C2 | Ukraine | C2 | |
| DE602004010137T2 | Germany | T2 | |
| NZ544076A | New Zealand | A | |
| AU2004240704B2 | Australia | B2 | |
| US7585845B2 | United States of America | B2 | |
| AU2004240704B9 | Australia | B9 | |
| JP2010043129A | Japan | A | |
| JP4447603B2 | Japan | B2 | |
| TWI327145B | Taiwan Province of China | B | |
| RS51294B | Serbia | B | |
| MY143076A | Malaysia | A | |
| CA2522577C | Canada | C | |
| ME00382B | Montenegro | B | |
| MEP58308A | Montenegro | A | |
| US7939667B2 | United States of America | B2 | |
| US2011177030A1 | United States of America | A1 | |
| IL172013A | Israel | A | |
| US8067438B2 | United States of America | B2 | |
| US2012034187A1 | United States of America | A1 | |
| KR101115294B1 | Republic of Korea | B1 | |
| NO332056B1 | Norway | B1 | |
| US2012269769A1 | United States of America | A1 | |
| CY1107200T1 | Cyprus | T1 | |
| CN103203010A | China | A | |
| CN103204903A | China | A | |
| BRPI0410456B1 | Brazil | B1 | |
| BRPI0410456B8 | Brazil | B8 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 4733750
Titles2
- German
- VERBINDUNGEN ALS HEPATITIS C INHIBITOREN
- English
- COMPOUNDS AS HEPATITIS C INHIBITORS
Classification
- CPC, 11
- A61K31/4709
- A61K38/06
- A61K38/212
- A61P1/16
- A61P31/00
- A61P31/12
- A61P31/14
- A61P43/00
- C07K5/0808
- C07K5/0827
- Y02A50/30
- IPC, 7
- A61K31 4709
- A61K38 00
- A61K38 21
- A61P31 00
- C07D417 04
- C07K5 08
- C07K5 083